This topic contains a solution. Click here to go to the answer

Author Question: The substance within the body that is responsible for preventing atelectasis is: A) alveolar ... (Read 56 times)

vicky

  • Hero Member
  • *****
  • Posts: 586
The substance within the body that is responsible for preventing atelectasis is:
 
  A) alveolar fluid.
  B) surfactant.
  C) pleural fluid.
  D) atelectasis fluid.

Question 2

All of the following are disadvantages of the LMA-Fastrach, EXCEPT:
 
  A) it can facilitate blind endotracheal intubation.
  B) its inability to decompress the stomach.
  C) its absence of sizes for patients less than 30 kg.
  D) its temperamental positioning.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Jadwiga9

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

B

Answer to Question 2

A




vicky

  • Member
  • Posts: 586
Reply 2 on: Jul 2, 2018
Excellent


amandanbreshears

  • Member
  • Posts: 320
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library